Hakutulokset - Tsai, Max

Paclitaxel-loaded polymeric microparticles: Quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics Tekijä Tsai, Max, Lu, Ze, Wientjes, M. Guillaume, Au, Jessie L.-S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol Tekijä Tsai, Max, Case, Michael, Ardayfio, Paul, Hochstetler, Helen, Wilbraham, Darren

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor Tekijä Tsai, Max, Chrones, Lambros, Xie, Jinhui, Gevorkyan, Hakop, Macek, Thomas A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis Tekijä Naik, Himanshu, Tsai, Max C., Fiedler-Kelly, Jill, Qiu, Ping, Vakilynejad, Majid

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus Tekijä Dudkowski, Caroline, Tsai, Max, Liu, Jie, Zhao, Zhen, Schmidt, Eric, Xie, Jeannie

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects Tekijä Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Kielbasa, William

Hae kokoteksti Hae kokoteksti Hae kokoteksti

TUMOR PENETRATING MICROPARTICLES FOR INTRAPERITONEAL THERAPY OF OVARIAN CANCER Tekijä Lu, Ze, Tsai, Max, Lu, Dan, Wang, Jie, Wientjes, M. Guillaume, Au, Jessie L.-S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults Tekijä Webb, Nicholas J. A., Wells, Thomas, Tsai, Max, Zhao, Zhen, Juhasz, Attila, Dudkowski, Caroline

Hae kokoteksti Hae kokoteksti Hae kokoteksti

EFFECTS OF CARRIER ON DISPOSITION AND ANTITUMOR ACTIVITY OF INTRAPERITONEAL PACLITAXEL Tekijä Tsai, Max, Lu, Ze, Wang, Jie, Yeh, Teng-Kuang, Wientjes, M. Guillaume, Au, Jessie L.-S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease Tekijä Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Pugh, Melissa, Ardayfio, Paul, Kielbasa, William

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Multiscale Tumor Spatiokinetic Model for Intraperitoneal Therapy Tekijä Au, Jessie L.-S., Guo, Peng, Gao, Yue, Lu, Ze, Wientjes, Michael G., Tsai, Max, Wientjes, M. Guillaume

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study Tekijä Wilbraham, Darren, Berg, Paul H., Tsai, Max, Liffick, Emily, Loo, Li Shen, Doty, Erin Gautier, Sellers, Edward

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationsh... Tekijä Goldsmith, Paul, Affinito, John, McCue, Maggie, Tsai, Max, Roepcke, Stefan, Xie, Jinhui, Gertsik, Lev, Macek, Thomas A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls Tekijä Pearlman, Eric M., Wilbraham, Darren, Dennehy, Ellen B., Berg, Paul H., Tsai, Max, Doty, Erin G., Kay, Gary G.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine Tekijä Tsai, Max, Nery, Emel Serap Monkul, Kerr, Lisa, Khanna, Rashna, Komori, Mika, Dennehy, Ellen B., Wilbraham, Darren, Winner, Paul

Hae kokoteksti Hae kokoteksti Hae kokoteksti

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients Tekijä Gilleen, James, Farah, Yakub, Davison, Cate, Kerins, Sarah, Valdearenas, Lorena, Uz, Tolga, Lahu, Gez, Tsai, Max, Ogrinc, Frank, Reichenberg, Avi, Williams, Steve C., Mehta, Mitul A., Shergill, Sukhi S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti